Pathological Features of Echovirus-11-Associated Brain Damage in Mice Based on RNA-Seq Analysis.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
10 12 2021
Historique:
received: 18 11 2021
revised: 07 12 2021
accepted: 07 12 2021
entrez: 28 12 2021
pubmed: 29 12 2021
medline: 1 2 2022
Statut: epublish

Résumé

Echovirus 11 (E11) is a neurotropic virus that occasionally causes fatal neurological diseases in infected children. However, the molecular mechanism underlying the disease and pathological spectrum of E11 infection remains unclear. Therefore, we modelled E11 infection in 2-day-old type I interferon receptor knockout (IFNAR-/-) mice, which are susceptible to enteroviruses, with E11, and identified symptoms consistent with the clinical signs observed in human cases. All organs of infected suckling mice were found to show viral replication and pathological changes; the muscle tissue showed the highest viral replication, whereas the brain and muscle tissues showed the most obvious pathological changes. Brain tissues showed oedema and a large number of dead nerve cells; RNA-Seq analysis of the brain and hindlimb muscle tissues revealed differentially expressed genes to be abundantly enriched in immune response-related pathways, with changes in the Guanylate-binding protein (GBP) and MHC class genes, causing aseptic meningitis-related symptoms. Furthermore, human glioma U251 cell was identified as sensitive target cells for E11 infection. Overall, these results provide new insights into the pathogenesis and progress of aseptic meningitis caused by E11.

Identifiants

pubmed: 34960747
pii: v13122477
doi: 10.3390/v13122477
pmc: PMC8707869
pii:
doi:

Substances chimiques

Ifnar1 protein, mouse 0
Receptor, Interferon alpha-beta 156986-95-7

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

J Neurosci Res. 1993 Nov 1;36(4):382-90
pubmed: 7903705
Virus Evol. 2020 May 10;6(1):veaa029
pubmed: 32411392
J Virol. 2001 Aug;75(16):7399-409
pubmed: 11462012
J Hyg (Lond). 1985 Oct;95(2):483-92
pubmed: 4067300
Proc Natl Acad Sci U S A. 1990;87 Suppl:10069-240
pubmed: 2243840
Virology. 2009 Feb 5;384(1):209-15
pubmed: 19059617
PLoS One. 2016 Aug 30;11(8):e0161656
pubmed: 27575749
J Virol. 1995 Aug;69(8):4792-6
pubmed: 7609046
J Interferon Cytokine Res. 2015 Apr;35(4):252-64
pubmed: 25714109
PLoS Pathog. 2018 Aug 3;14(8):e1007235
pubmed: 30075026
Proc Natl Acad Sci U S A. 1979 Oct;76(10):4817-21
pubmed: 291901
J Virol. 1997 Jan;71(1):383-91
pubmed: 8985361
EMBO J. 2001 Oct 15;20(20):5568-77
pubmed: 11598000
Nat Commun. 2016 Jul 01;7:12077
pubmed: 27363812
Vet J. 2016 Dec;218:71-77
pubmed: 27938713
Virology. 2011 Mar 30;412(1):91-100
pubmed: 21262515
Front Microbiol. 2021 Jun 18;12:663019
pubmed: 34220748
Front Genet. 2019 Nov 12;10:1152
pubmed: 31781178
Virology. 1999 Mar 30;256(1):8-14
pubmed: 10087221
J Microbiol Immunol Infect. 2021 Aug;54(4):581-587
pubmed: 32653431
Biochem Biophys Res Commun. 2017 May 6;486(3):706-711
pubmed: 28342868
J Virol. 2012 Dec;86(23):13062-9
pubmed: 23015694
J Proteome Res. 2013 Jun 7;12(6):2666-78
pubmed: 23647205
PLoS Pathog. 2021 Jan 29;17(1):e1009252
pubmed: 33513208
Sci Rep. 2018 Mar 6;8(1):4087
pubmed: 29511232
J Biol Chem. 1983 Jun 25;258(12):7746-50
pubmed: 6305951
Kansenshogaku Zasshi. 1994 Oct;68(10):1251-5
pubmed: 7996023
BMC Infect Dis. 2015 Jun 11;15:225
pubmed: 26058678
Front Cell Infect Microbiol. 2016 Dec 21;6:192
pubmed: 28066727
Cell Host Microbe. 2016 Apr 13;19(4):504-14
pubmed: 26996307
Science. 2012 Apr 27;336(6080):481-5
pubmed: 22461501
Proc Natl Acad Sci U S A. 1985 Aug;82(16):5505-9
pubmed: 2991930
Lancet. 2002 Feb 9;359(9305):507-13
pubmed: 11853816
EMBO J. 2003 Aug 1;22(15):3772-82
pubmed: 12881412
Epidemiol Infect. 2001 Jun;126(3):441-4
pubmed: 11467801
Front Microbiol. 2020 Nov 25;11:593857
pubmed: 33324374
Emerg Microbes Infect. 2019;8(1):1445-1455
pubmed: 31595827

Auteurs

Guoyan Zhang (G)

WHO WPRO Regional Polio Reference Laboratory, National Health Commission Key Laboratory for Biosafety, National Health Commission Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 155 Changbai Road, Beijing 102206, China.
Biosafety Level-3 Laboratory, National Health Commission Key Laboratory for Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 155 Changbai Road, Beijing 102206, China.

Jichen Li (J)

WHO WPRO Regional Polio Reference Laboratory, National Health Commission Key Laboratory for Biosafety, National Health Commission Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 155 Changbai Road, Beijing 102206, China.
Department of Medical Microbiology, Weifang Medical University, Weifang 261053, China.

Qiang Sun (Q)

WHO WPRO Regional Polio Reference Laboratory, National Health Commission Key Laboratory for Biosafety, National Health Commission Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 155 Changbai Road, Beijing 102206, China.

Keyi Zhang (K)

WHO WPRO Regional Polio Reference Laboratory, National Health Commission Key Laboratory for Biosafety, National Health Commission Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 155 Changbai Road, Beijing 102206, China.
Biosafety Level-3 Laboratory, National Health Commission Key Laboratory for Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 155 Changbai Road, Beijing 102206, China.

Wenbo Xu (W)

WHO WPRO Regional Polio Reference Laboratory, National Health Commission Key Laboratory for Biosafety, National Health Commission Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 155 Changbai Road, Beijing 102206, China.
Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan 430071, China.

Yong Zhang (Y)

WHO WPRO Regional Polio Reference Laboratory, National Health Commission Key Laboratory for Biosafety, National Health Commission Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 155 Changbai Road, Beijing 102206, China.
Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan 430071, China.

Guizhen Wu (G)

Biosafety Level-3 Laboratory, National Health Commission Key Laboratory for Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 155 Changbai Road, Beijing 102206, China.
Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan 430071, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH